Status:
UNKNOWN
A Randomized, Double-Blind, Placebo-Controlled Study of Gastroesophageal Reflux Disease Therapy.
Lead Sponsor:
Emory University
Conditions:
Asthma
Eligibility:
All Genders
4-11 years
Phase:
PHASE4
Brief Summary
Asthma and gastroesophageal reflux disease (GERD) are common disorders, which although are not usually lethal, both have high morbidity, and high healthcare costs. Recent studies have demonstrated tha...
Detailed Description
GERD and asthma likely co-exist, and may be pathogenetically linked. However, it is controversial whether GERD per se is an important risk factor for severe asthma, and whether treatment of GERD and/o...
Eligibility Criteria
Inclusion
- 4-11 years Informed Consent/ Assent Asthma Clinically normal laboratory results and physical exam
Exclusion
- Unable or unwilling to give informed consent Unable to comply with study protocol Any preexisting condition that would require A PPI for a period of 6 months or more and/other major chronic illnesses.
- Drug Allergies toPPI. At High risk for non-compliance and/or adherence.
Key Trial Info
Start Date :
March 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2010
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00237068
Start Date
March 1 2006
End Date
December 1 2010
Last Update
March 16 2011
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Emory Children's Center
Atlanta, Georgia, United States, 30322
2
Children's Center for Digestive Healthcare
Atlanta, Georgia, United States, 30342
3
Georgia Pediatric Pulmonology Associates/ CHOA
Atlanta, Georgia, United States, 30342